Skip to content

Clinical trials

Insulin Resistance trials with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Not applicable Status: Unknown status Clear all

164 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20044
20052
20061
20071
20082
200910
20105
20114
20126
201311
201412
20158
201610
20175
201815
201916
20209
20218
202212
202313
20247

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status164

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Copenhagen4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
Augusta University3
Federal University of São Paulo3
Hospital de Clinicas de Porto Alegre3
University of Virginia3
Isfahan University of Medical Sciences2
Istanbul Medeniyet University2
McGill University Health Centre/Research Institute of the McGill University Health Centre2
National Institute on Aging (NIA)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance164
Obesity38
Diabetes Mellitus, Type 231
Diabetes Mellitus25
Metabolic Syndrome23
Inflammation9
Glucose Intolerance8
Polycystic Ovary Syndrome8
Prediabetic State8
Hyperglycemia7

Trials

Showing 1 to 25 of 164. Each trial links to its page on Pharma Observatory.

64 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.